Vistra Corp.

**Signal Note: Eventide Adds Nuclear Energy Play** Eventide's $78.7M entry into Vistra (nuclear power operator) signals conviction in energy infrastructure supporting AI/data center demand, likely benefiting biotech manufacturing and operational costs. This represents a notable portfolio allocation shift toward non-biotech but complementary sector exposure, suggesting Eventide sees structural tailwinds in power supply for biotech and life sciences infrastructure.